BMA attacks value-based drug pricing plans

Proposals for value-based pricing of drugs will create an 'excessively burdensome and bureaucratic' system, the BMA has warned.

Its response to a DoH consultation on drug pricing said the current arrangements 'look increasingly inappropriate' as NHS resources are squeezed.

Leaving commissioners to make decisions on specialist drugs could widen 'postcode rationing and the pillorying of commissioning groups', it said.

Dr Brian Karet, RCGP clinical lead for diabetes, said GP commissioners would soon have to make decisions about expensive drugs that PCTs had been reluctant to fund.

'These things should be done through the design of care pathways,' he said.

'They should be part of an agreed care package involving patients and clinicians. It is not just about arbitrary decisions.'

The BMA said the plans on drug pricing were too lacking in detail to assess properly.

The 'generic nature of the proposals makes it difficult to draw a firm conclusion' as to their overall merits, it said.

The BMA also stressed there was no reason the move would cut NHS prescribing costs. It raised doubts about the practicality and legality of assigning different prices for the same drug depending on the condition it was being used to treat.

The BMA also warned the proposals did not take into account international trade in medicines. 'It is uncertain how much impact the profits that a company will make from sales in the NHS will influence the development priorities of companies that are multinational and will get a larger return from overseas sales,' the BMA response said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Doctors are being 'taxed out of the NHS', warns BMA chair

Doctors are being 'taxed out of the NHS', warns BMA chair

The NHS risks being brought to a standstill because 'perverse and punitive pension...

Welsh GP contract deal delivers £25m funding boost and partner incentives

Welsh GP contract deal delivers £25m funding boost and partner incentives

GPs in Wales will receive a £25m increase in funding in 2019/20 as part of a new...

Elected BMA members to receive equality training after sexism investigation

Elected BMA members to receive equality training after sexism investigation

BMA chair Dr Chaand Nagpaul has promised that the association will 'learn, act and...

NHS Resolution moves to allay fears over state indemnity 'small print'

NHS Resolution moves to allay fears over state indemnity 'small print'

Information about GPs will only be passed to the GMC under 'very rare circumstances'...

BMA U-turn over sexism and harassment debate at annual conference

BMA U-turn over sexism and harassment debate at annual conference

Doctors' leaders will debate claims that the BMA fails to address sexism and harassment...

Doctors begin giving evidence in BMA sexism investigation

Doctors begin giving evidence in BMA sexism investigation

Doctors have started giving evidence as part of the investigation into sexism and...